Warner Chilcott Faces Fresh Suit Over Doryx Generic Ploy

Law360, New York (February 6, 2013, 4:52 PM EST) -- Walgreen Co., Safeway Inc. and others launched a suit in Pennsylvania federal court Tuesday accusing Warner Chilcott PLC of improperly preventing competitors from developing a generic form of skin infection drug Doryx, the latest suit Warner Chilcott faces over the drug.

Walgreen, Safeway, Supervalu Inc. and Heb Grocery Co. LP claim that Warner Chilcott violated the Sherman Act by engaging in a scheme to maintain and extend its monopoly power for Doryx by tweaking the drug's design in order to extend its patents, causing the retailers...
To view the full article, register now.